FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Real-time Boerse Frankfurt Warrants 02:18:11 29/05/2024 pm IST | ||
| 1.33 EUR | -0.75% |
|
| Current month | -25.56% | ||
| 1 month | -30.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 29/24/29 | 1.33 | -0.75% |
| 28/24/28 | 1.34 | -6.29% |
| 27/24/27 | 1.43 | +0.70% |
| 24/24/24 | 1.42 | -2.74% |
| 23/24/23 | 1.46 | -5.19% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 02:18 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB01G8 |
| ISIN | DE000SB01G83 |
| Date issued | 09/06/2020 |
| Strike | 61.28 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.65 € |
|---|---|
| Lowest since issue | 1.32 € |
| Spread | 0.02 € |
| Spread % | 1.48% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.49
USD
Average target price
53.19
USD
Spread / Average Target
+31.38%
- Stock Market
- Certificates
- Certificat
